Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07020936 · ClinicalTrials.gov registry record · NA

AIDANET Pediatrics

A NA study of Type 1 Diabetes, sponsored by Mark D. DeBoer, MD, MSc., MCR.

Recruiting
Registry status
NA
Development phase
36
Enrollment target
3
Study locations

NCT07020936 is a NA study of Type 1 Diabetes that is actively recruiting participants, run by Mark D. DeBoer, MD, MSc., MCR. The registered enrollment target is 36 participants, below the 824-participant average among 178 other Type 1 Diabetes trials with a reported enrollment target (96% lower). The trial reports 3 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07020936, a NA study of Type 1 Diabetes, is actively recruiting participants, sponsored by Mark D. DeBoer, MD, MSc., MCR.

RECRUITING
Registry status
NA
Development phase
36 participants
Enrollment target
3
Study locations

Study Summary

AIDANET algorithm with smart-phone based control system (study smart phone), specifically modified Tandem insulin system (study insulin pump), and Dexcom G6 CGM (study CGM).

Conditions Studied

Interventions

  • DEVICE Normal Glycemia Goal
  • DEVICE Tight Glycemia Goal

Study Locations (3)

California

  • University of California San Francisco - San Francisco

Colorado

  • Barbara Davis Center, University of Colorado - Aurora

Virginia

  • University of Virginia Center for Diabetes Technology - Charlottesville

Trial Details

FieldValue
Enrollment Target 36 participants
Start Date 2025-07-21
Est. Completion 2026-03-30
Phase NA

Sponsor

Mark D. DeBoer, MD, MSc., MCR

2 total trials

What the Registry Record Tells You About NCT07020936

The ClinicalTrials.gov registry entry for NCT07020936 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 824-participant average among 178 other Type 1 Diabetes trials with a reported enrollment target (96% lower). The listed sponsor is Mark D. DeBoer, MD, MSc., MCR, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Type 1 Diabetes appearing as the primary indexed condition, and to 2 interventions - of which Normal Glycemia Goal is the first listed.

NCT07020936 reports 3 study locations spanning 3 distinct geographic areas - top geographies include California, Colorado, Virginia.

Frequently Asked Questions

What is clinical trial NCT07020936 about?

NCT07020936 is a clinical study titled "AIDANET Pediatrics". AIDANET algorithm with smart-phone based control system (study smart phone), specifically modified Tandem insulin system (study insulin pump), and Dexcom G6 CGM (study CGM).

What is the current status of trial NCT07020936?

This trial is currently recruiting. It is a NA study. The enrollment target is 36 participants. The study started on 2025-07-21. Estimated completion is 2026-03-30.

What conditions does trial NCT07020936 study?

This clinical trial studies the following conditions: Type 1 Diabetes.

What interventions are being tested in trial NCT07020936?

The interventions under investigation include: Normal Glycemia Goal (DEVICE), Tight Glycemia Goal (DEVICE).

Who is sponsoring clinical trial NCT07020936?

This trial is sponsored by Mark D. DeBoer, MD, MSc., MCR, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07020936 being conducted?

This trial has 3 study locations across California, Colorado, Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Type 1 Diabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.